Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone

被引:5
|
作者
Zhao, Ying-Ying [1 ]
Xiong, Mei-Lian [2 ]
Liu, Yue-Feng [3 ]
Duan, Li-Juan [1 ]
Chen, Jia-Li [1 ]
Xing, Zhen [2 ]
Lin, Yan-Shun [1 ]
Chen, Tan-Hui [2 ]
机构
[1] Fujian Med Univ, Fuqing City Hosp, Dept Radiol, Fuqing, Peoples R China
[2] Fujian Med Univ, Dept Nephrol, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China
[3] Hubei Univ Med, Taihe Hosp, Dept Ophthalmol, Shiyan, Hubei, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
magnetic resonance imaging; prostate cancer; PI-RADS; transitional zone; radiomics; MR; CLASSIFICATION; ASSOCIATION; STATISTICS; BIOPSY; SCORE; RISK;
D O I
10.3389/fonc.2023.1247682
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This bi-institutional study aimed to establish a robust model for predicting clinically significant prostate cancer (csPCa) (pathological grade group >= 2) in PI-RADS 3 lesions in the transition zone by comparing the performance of combination models.Materials and methods: This study included 243 consecutive men who underwent 3-Tesla magnetic resonance imaging (MRI) and ultrasound-guided transrectal biopsy from January 2020 and April 2022 which is divided into a training cohort of 170 patients and a separate testing cohort of 73 patients. T2WI and DWI images were manually segmented for PI-RADS 3 lesions for the mean ADC and radiomic analysis. Predictive clinical factors were identified using both univariate and multivariate logistic models. The least absolute shrinkage and selection operator (LASSO) regression models were deployed for feature selection and for constructing radiomic signatures. We developed nine models utilizing clinical factors, radiological features, and radiomics, leveraging logistic and XGboost methods. The performances of these models was subsequently compared using Receiver Operating Characteristic (ROC) analysis and the Delong test.Results: Out of the 243 participants with a median age of 70 years, 30 were diagnosed with csPCa, leaving 213 without a csPCa diagnosis. Prostate-specific antigen density (PSAD) stood out as the only significant clinical factor (odds ratio [OR], 1.068; 95% confidence interval [CI], 1.029-1.115), discovered through the univariate and multivariate logistic models. Seven radiomic features correlated with csPCa prediction. Notably, the XGboost model outperformed eight other models (AUC of the training cohort: 0.949, and validation cohort: 0.913). However, it did not surpass the PSAD+MADC model (P > 0.05) in the training and testing cohorts (AUC, 0.949 vs. 0.888 and 0.913 vs. 0.854, respectively).Conclusion: The machine learning XGboost model presented the best performance in predicting csPCa in PI-RADS 3 lesions within the transitional zone. However, the addition of radiomic classifiers did not display any significant enhancement over the compound model of clinical and radiological findings. The most exemplary and generalized option for quantitative prostate evaluation was Mean ADC+PSAD.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Magnetic Resonance Elastography Combined With PI-RADS v2.1 for the Identification of Clinically Significant Prostate Cancer
    Chen, Jie
    Chen, Yuntian
    Chen, Guoyong
    Deng, Liping
    Yuan, Yuan
    Tang, Hehan
    Zhang, Zhen
    Chen, Tingyu
    Zeng, Hao
    Yuan, Enyu
    Yin, Meng
    Chen, Jun
    Song, Bin
    Yao, Jin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2024,
  • [22] Radiomic-based model for prediction of clinically significant prostate cancer in patients with a PI-RADS 3 MRI lesion
    Nguyen, T. A.
    Tixier, F.
    Tissot, V
    Fourcade, A.
    Saout, K.
    Zambon, A.
    Payrard, C.
    Deruelle, C.
    Joulin, V
    Doucet, L.
    Visvikis, D.
    Fournier, G.
    Valeri, A.
    EUROPEAN UROLOGY, 2022, 81 : S422 - S423
  • [23] Are upgraded DCE-positive PI-RADS 3 lesions truly suspicious for clinically significant prostate cancer?
    Patrick Asbach
    Anwar R. Padhani
    European Radiology, 2023, 33 : 5825 - 5827
  • [24] Are upgraded DCE-positive PI-RADS 3 lesions truly suspicious for clinically significant prostate cancer?
    Asbach, Patrick
    Padhani, Anwar R.
    EUROPEAN RADIOLOGY, 2023, 33 (08) : 5825 - 5827
  • [25] MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI
    Chen, Tong
    Zhang, Zhiyuan
    Tan, Shuangxiu
    Zhang, Yueyue
    Wei, Chaogang
    Wang, Shan
    Zhao, Wenlu
    Qian, Xusheng
    Zhou, Zhiyong
    Shen, Junkang
    Dai, Yakang
    Hu, Jisu
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [26] PI-RADS 3 score: A retrospective experience of clinically significant prostate cancer detection
    Camacho, Andres
    Salah, Fatima
    Bay, Camden P.
    Waring, Jonathan
    Umeton, Renato
    Hirsch, Michelle S.
    Cole, Alexander P.
    Kibel, Adam S.
    Loda, Massimo
    Tempany, Clare M.
    Fennessy, Fiona M.
    BJUI COMPASS, 2023, 4 (04): : 473 - 481
  • [27] Editorial for "Magnetic Resonance Elastography Combined With PI-RADS v2.1 for the Identification of Clinically Significant Prostate Cancer"
    Lee, Kang-Lung
    Kessler, Dimitri A.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2024,
  • [28] Nomograms for predicting clinically significant prostate cancer in men with PI-RADS-3 biparametric magnetic resonance imaging
    Liang, Zhen
    Feng, Tianrui
    Zhou, Yi
    Yang, Yongjiao
    Sun, Yujiao
    Zhou, Zhien
    Yan, Weigang
    Cao, Fenghong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (01):
  • [29] Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
    Osses, Daniel F.
    Arsov, Christian
    Schimmoeller, Lars
    Schoots, Ivo G.
    van Leenders, Geert J. L. H.
    Esposito, Irene
    Remmers, Sebastiaan
    Albers, Peter
    Roobol, Monique J.
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 13
  • [30] CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTION RATES IN PI-RADS 3 LESIONS ON MPMRI: RISK STRATIFIED BY PSA DENSITY
    Huang, Karen
    Ou, Michelle
    Chaudhary, Sarah
    Hall, Simon J.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E313 - E313